Dr. Bruce Lahn Named to 2024 PharmaVoice 100 for Leadership in Biotechnology

Dr. Bruce Lahn, Chief Scientist at VectorBuilder, has been named to the prestigious 2024 PharmaVoice 100 list, recognizing his significant contributions to genetic engineering and biotechnology. Under his leadership, VectorBuilder is advancing gene delivery solutions, crucial for personalized medicine and innovative therapies. This accolade highlights the importance of visionary leaders in the pharmaceutical industry, shaping the future of healthcare and improving patient outcomes.